529-33-9 | 1,2,3,4-Tetrahydro-1-naphthol

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$11.00	$8.00
10g	98%	in stock	$21.00	$15.00
25g	98%	in stock	$33.00	$24.00
100g	98%	in stock	$118.00	$83.00

Description

• Catalog Number: AB56974
• Chemical Name: 1,2,3,4-Tetrahydro-1-naphthol
• CAS Number: 529-33-9
• Molecular Formula: C10H12O
• Molecular Weight: 148.20167999999998
• MDL Number: MFCD00001739
• SMILES: OC1CCCc2c1cccc2
• NSC Number: 5172

Computed Properties

• Complexity: 133
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Undefined Atom Stereocenter Count: 2
• XLogP3: 1.8

Literature

• Gold nanoparticles incarcerated in nanoporous syndiotactic polystyrene matrices as new and efficient catalysts for alcohol oxidations.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120109

• Synthesis of novel mast cell-stabilising and anti-allergic 1,2,3,4-tetrahydro-1-naphthalenols and related compounds.

  European journal of medicinal chemistry 20110501

• Spectroscopic investigations on Naphthol and Tetrahydronaphthol. A theoretical approach.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110201

• To remove or not to remove? The challenge of extracting the template to make the cavities available in Molecularly Imprinted Polymers (MIPs).

  International journal of molecular sciences 20110101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents.

  Bioorganic & medicinal chemistry letters 20091115

• An inner pore residue (Asn406) in the Nav1.5 channel controls slow inactivation and enhances mibefradil block to T-type Ca2+ channel levels.

  Molecular pharmacology 20061101

• Monocyclic and dicyclic hydrocarbons: structural requirements for proximal giant axonopathy.

  Acta neuropathologica 20060901

• Breakdown products on metabolic pathway of degradation of benz[a]anthracene by a ligninolytic fungus.

  Chemosphere 20060701

• Aryltetralol and aryltetralone lignans from Holostylis reniformis.

  Phytochemistry 20060501

• Mode of binding of methyl acceptor substrates to the adrenaline-synthesizing enzyme phenylethanolamine N-methyltransferase: implications for catalysis.

  Biochemistry 20051227

• Sub- and supercritical chiral separation of racemic compounds on columns with stationary phases having different functional groups.

  Chemical & pharmaceutical bulletin 20051001

• Unexpectedly small ortho-oxygen substituent effects on stabilities of benzylic carbocations.

  Journal of the American Chemical Society 20040818

• Dopamine-induced death of PC12 cells is prevented by a substituted tetrahydronaphthalene.

  Neuropharmacology 20040601

• Influence of phenylalanines 77 and 138 on the stereospecificity of aryl sulfotransferase IV.

  Drug metabolism and disposition: the biological fate of chemicals 20040501

• Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.

  Journal of medicinal chemistry 20021205

• Enantioselective routes to both enantiomers of aryl alcohols with a single catalyst antipode: Ru and Os transfer hydrogenation catalysts.

  Organic letters 20011115

• Evidence against an action of mibefradil at N-type voltage-operated calcium channels.

  Naunyn-Schmiedeberg's archives of pharmacology 20011101